Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Telithromycin vs Moxifloxacin in Acute Maxillary Sinusitis
NCT00537563Phase 3Completed
- Sponsor
- Sanofi
- Start
- Dec 2002
- Primary completion
- Sep 2003
- Modality
- Covalent Small Molecules, Classical Binding Small Molecules, Nucleic Acid-Directed Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of telithromycin in Acute maxillary sinusitis (AMS) (2 arms), sponsored by Sanofi. Primary endpoint: Clinical Efficacy at Test of Cure. Started Dec 2002; status: completed.
02
Drugs
telithromycin
03
Conditions
Acute maxillary sinusitis (AMS)
Beyond the preview
Go deeper on NCT00537563.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00537563.